Clinical pathway to identify patients with acquired hemophilia
This example algorithm was developed by Novo Nordisk in collaboration with experts and follows the latest treatment guidelines. It is meant to raise awareness of common steps for assessing patients and diagnosing acquired hemophilia in the emergency department (ED) setting.a
Clinical pathway to identify patients with acquired hemophilia
This example algorithm was developed by Novo Nordisk in collaboration with experts and follows the latest treatment guidelines. It is meant to raise awareness of common steps for assessing patients and diagnosing acquired hemophilia in the emergency department (ED) setting.a
aThe provided example is for discussion purposes only and is not intended to represent a recommended algorithm for actual decision making. This example is for illustrative purposes and does not constitute guidance for medical advice or treatment.
Now that you’ve reviewed common steps for assessing and treating a patient for acquired hemophilia, you may be interested in an illustrative patient case example.
Now that you’ve reviewed common steps for assessing and treating a patient for acquired hemophilia, you may be interested in an illustrative patient case example.
References:
- Kruse-Jarres R, Kempton C, Baudo F et al. Acquired hemophilia A: Updated review of evidence and treatment guidance. Am J Hematol. 2017;92:695–705.
- Shander A, Walsh CE, Cromwell C. Acquired hemophilia: a rare but life-threatening potential cause of bleeding in the intensive care unit. Intensive Care Med. 2011;37(8):1240-1249.
- Knoebl P, Marco P, Baudo F, et al; EACH2 Registry Contributors. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012;10(4):622-631.